Great analysis. My question is: while focusing on Pfizer are we ignoring Moderna a company with zippo clinical track record and deep ties to NIH? Is there a FOIA in the works for Moderna too? And the complacent NEJM who published these trials despite math errors in numbers of enrollees who were discontinued? Can we call into question the NEJM peer review process? Don’t try to contact the authors of Polack and Thomas (Pfizer 6 mos) studies. They have all left. Only deep Pfizer employees will address questions about data and even then they give inadequate answers. Thank you for doing the deep dive needed.